Mitrecin A , an endolysin‐like bacteriolytic enzyme from a newly isolated soil streptomycete

Abstract

An open reading frame with homology to known endolysin genes was identified in the genome of Streptomyces sp. strain 212, which is a newly isolated soil bacterium. The heterologously expressed gene product of this endolysin-like gene, called Mitrecin A, demonstrated bacteriolytic activity against several Gram-negative bacteria. The genome of the bacterial strain was sequenced to draft quality using pyrosequencing followed by genome assembly and gene annotation. Within the sequence, a chromosomally located endolysin-like open reading frame was predicted. The gene product, designated Mitrecin A, was heterologously expressed and isolated from contaminating proteins as a fusion protein to a 6-histidine tag. Mitrecin A consists of 127 amino acids arranged in modular domains of activity. It has an estimated molecular weight of 14·3 kDa and retains sequence homology to the M15C peptidase subfamily of zinc metallocarboxypeptidases. The heat-labile purified recombinant protein has an overall positive charge, has optimal catalytic activities at 26°C in solution of pH 9 with 1% saline and has bacteriolytic activity against Gram-negative bacteria of the medically important genera Aeromonas, Escherichia, Salmonella, Shigella, Vibrio and Yersinia.Significance and Impact of the StudyThe gene of a new protein antimicrobial, Mitrecin A, was discovered in the genome of a soil bacterium. The purified recombinant enzyme, resulting from heterologous over expression of the gene, was found to be tolerant of increased pH conditions and to have bacteriolytic activity against Gram-negative bacteria of the medically important genera Aeromonas, Escherichia, Salmonella, Shigella, Vibrio and Yersinia. Characterization of enzymes such as Mitrecin A from previously uncharacterized bacteria provides potential options for new biocontrol agents in medically and economically important applications like therapeutics, disinfectants, food preservatives, agricultural livestock antimicrobials, and inhibitors of biofilm production.

Littoral lichens as a novel source of potentially bioactive Actinobacteria

“…Furthermore, a large numbers of streptomycetes were also isolated from these lichens. Although members of this genus are often considered a “spent force” in terms of biodiscovery, one has to note that at least 13 novel biomolecules have been reported from this taxa in the first half of 2014 alone 37 38 39 40 41 42 43 44 45 46 47 48 . Additionally, Takagi and Shin-ya (2011) 49 have shown novelty in actinobacterial taxa alone does not always mean the presence of novel bioactive compounds.…”

Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria

“…Endolysins can also be expressed by transgenic plants to prevent infection by phytopathogenic bacteria ( Oey et al, 2009 ). Expanding databases of predicted proteins from the increasing number of sequenced and annotated bacterial genomes present a growing number of potential endolysins ( Schmitz et al, 2010 ; Farris and Steinberg, 2014 ). As multidrug-resistant strains are becoming more prevalent, endolysins may be employed as novel alternatives to antibiotics ( Bragg et al, 2014 ; Yang et al, 2014 ).…”

Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence

“…For AMPs to become a therapeutic option several challenges must be overcome, including antibacterial effectiveness in vitro and in vivo, along with low toxicity rates at the therapeutic dose [10]. The use of innovative rational and computational design strategies have the potential to increase the discovery of novel therapeutic peptides at a lower cost, with enhanced effectiveness and broad-spectrum activities [10,11].…”